These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1446 related items for PubMed ID: 15350319

  • 1. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma.
    Christiansen GA, Nau CB, McLaren JW, Johnson DH.
    Ophthalmology; 2004 Sep; 111(9):1658-62. PubMed ID: 15350319
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study.
    Lim KS, Nau CB, O'Byrne MM, Hodge DO, Toris CB, McLaren JW, Johnson DH.
    Ophthalmology; 2008 May; 115(5):790-795.e4. PubMed ID: 18452763
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N, Rossetti L, Bottoli A, Fogagnolo P.
    Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
    [Abstract] [Full Text] [Related]

  • 5. Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
    Cantor LB, WuDunn D, Cortes A, Hoop J, Knotts S.
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S12-8. PubMed ID: 15016557
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment.
    Johnson TV, Fan S, Zhan G, Camras CB, Toris CB.
    J Glaucoma; 2010 Aug; 19(6):356-64. PubMed ID: 20179619
    [Abstract] [Full Text] [Related]

  • 7. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC, Konstas AG, Nelson LA, Kruft B.
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of action of bimatoprost (Lumigan).
    Brubaker RF.
    Surv Ophthalmol; 2001 May; 45 Suppl 4():S347-51. PubMed ID: 11434937
    [Abstract] [Full Text] [Related]

  • 9. Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics.
    Brubaker RF, Schoff EO, Nau CB, Carpenter SP, Chen K, Vandenburgh AM.
    Am J Ophthalmol; 2001 Jan; 131(1):19-24. PubMed ID: 11162974
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
    Rossetti L, Karabatsas CH, Topouzis F, Vetrugno M, Centofanti M, Boehm A, Viswanathan A, Vorwerk C, Goldblum D.
    Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
    [Abstract] [Full Text] [Related]

  • 11. Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension.
    Katz LJ, Cohen JS, Batoosingh AL, Felix C, Shu V, Schiffman RM.
    Am J Ophthalmol; 2010 Apr; 149(4):661-671.e1. PubMed ID: 20346780
    [Abstract] [Full Text] [Related]

  • 12. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.
    Konstas AG, Katsimbris JM, Lallos N, Boukaras GP, Jenkins JN, Stewart WC.
    Ophthalmology; 2005 Feb; 112(2):262-6. PubMed ID: 15691561
    [Abstract] [Full Text] [Related]

  • 13. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
    Yildirim N, Sahin A, Gultekin S.
    J Glaucoma; 2008 Feb; 17(1):36-9. PubMed ID: 18303382
    [Abstract] [Full Text] [Related]

  • 14. Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice.
    Crowston JG, Lindsey JD, Morris CA, Wheeler L, Medeiros FA, Weinreb RN.
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4571-7. PubMed ID: 16303950
    [Abstract] [Full Text] [Related]

  • 15. The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension.
    Arcieri ES, Pierre Filho PT, Wakamatsu TH, Costa VP.
    Eye (Lond); 2008 Feb; 22(2):179-83. PubMed ID: 16936646
    [Abstract] [Full Text] [Related]

  • 16. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
    Wang RF, Gagliuso DJ, Mittag TW, Podos SM.
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
    [Abstract] [Full Text] [Related]

  • 17. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
    Denis P, Lafuma A, Khoshnood B, Mimaud V, Berdeaux G.
    Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
    [Abstract] [Full Text] [Related]

  • 18. Effect of flunarizine, a calcium channel blocker, on intraocular pressure and aqueous humor dynamics in monkeys.
    Wang RF, Gagliuso DJ, Podos SM.
    J Glaucoma; 2008 Mar; 17(1):73-8. PubMed ID: 18303390
    [Abstract] [Full Text] [Related]

  • 19. Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension.
    Cohen JS, Gross RL, Cheetham JK, VanDenburgh AM, Bernstein P, Whitcup SM.
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S45-52. PubMed ID: 15016561
    [Abstract] [Full Text] [Related]

  • 20. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
    Williams RD, Cohen JS, Gross RL, Liu CC, Safyan E, Batoosingh AL, Bimatoprost Study Group.
    Br J Ophthalmol; 2008 Oct; 92(10):1387-92. PubMed ID: 18621791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.